[go: up one dir, main page]

Lecolley et al., 2004 - Google Patents

A new approach to bioconjugates for proteins and peptides (“pegylation”) utilising living radical polymerisation

Lecolley et al., 2004

Document ID
14106562209524259130
Author
Lecolley F
Tao L
Mantovani G
Durkin I
Lautru S
Haddleton D
Publication year
Publication venue
Chemical Communications

External Links

Snippet

A new approach to bioconjugates for proteins and peptides (“pegylation”) utilising living radical polymerisation - Chemical Communications (RSC Publishing) DOI:10.1039/B407712A Royal Society of Chemistry ViewáPDFáVersionPreviousáArticleNextáArticle á DOI:á10.1039/B407712A …
Continue reading at pubs.rsc.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A61K47/48192—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes
    • A61K47/48215—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer, dendrimer, e.g. PEG, PPG, PEO, polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A61K47/4823—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative, e.g. starch, chitosan, chitin, cellulose, pectin, cyclodextrin with the pharmacologically active agent being covalently linked to the external surface of the ring structure, a bacterial polysaccharide or oligosaccharide antigen, a glycosaminoglycan
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule form cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
    • C08G65/3344—Polymers modified by chemical after-treatment with organic compounds containing sulfur containing oxygen in addition to sulfur
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
    • C08F293/005—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent

Similar Documents

Publication Publication Date Title
Lecolley et al. A new approach to bioconjugates for proteins and peptides (“pegylation”) utilising living radical polymerisation
Vanparijs et al. Polymer-protein conjugation via a ‘grafting to’approach–a comparative study of the performance of protein-reactive RAFT chain transfer agents
ES2324994T3 (en) INITIATOR FOR LIVE RADICAL POLYMERIZATION THAT INCLUDES A FUNCTIONAL GROUP THAT CAN REACT WITH POLYPEPTIDES OR SIMILAR, PEINE TYPE POLYMER OBTAINED WITH THE SAME, CONJUGATED WITH POLYPEPTIDE AND PHARMACOOBTENED FROM THE SAME.
Li et al. Block copolymer conjugates prepared by sequentially grafting from proteins via RAFT
Li et al. Thermoresponsive Block Copolymer–Protein Conjugates Prepared by Grafting‐from via RAFT Polymerization
Bays et al. Synthesis of semitelechelic maleimide poly (PEGA) for protein conjugation by RAFT polymerization
Chenal et al. First peptide/protein PEGylation with functional polymers designed by nitroxide-mediated polymerization
Li et al. Protein conjugation of thermoresponsive amine-reactive polymers prepared by RAFT
CN102317332B (en) Zwitterionic polymers with therapeutic moieties
Mantovani et al. Design and synthesis of N-maleimido-functionalized hydrophilic polymers via copper-mediated living radical polymerization: a suitable alternative to PEGylation chemistry
Tao et al. Branched polymer− protein conjugates made from mid-chain-functional P (HPMA)
Gauthier et al. Peptide/protein–polymer conjugates: synthetic strategies and design concepts
AU741166B2 (en) Heterofunctionalized star-shaped poly(ethylene glycols) for protein modification
Nicolas et al. Living radical polymerization as a tool for the synthesis of polymer‐protein/peptide bioconjugates
Magnusson et al. In Situ Growth of Side-Chain PEG Polymers from Functionalized Human Growth Hormone A New Technique for Preparation of Enhanced Protein− Polymer Conjugates
Jones et al. Highly efficient disulfide bridging polymers for bioconjugates from radical-compatible dithiophenol maleimides
Xia et al. Site-specific conjugation of RAFT polymers to proteins via expressed protein ligation
Bulmus RAFT polymerization mediated bioconjugation strategies
Vázquez-Dorbatt et al. Synthesis of aminooxy end-functionalized pNIPAAm by RAFT polymerization for protein and polysaccharide conjugation
US7786213B2 (en) Biomacromolecule polymer conjugates
Nauka et al. Enhancing the conjugation yield of brush polymer–protein conjugates by increasing the linker length at the polymer end-group
JP5017107B2 (en) Living radical polymerization initiator containing a functional group capable of reacting with a polypeptide, etc., comb polymer obtained by using the same, polypeptide complex and drug obtained therefrom
Johnson et al. Recent developments in polymer–block–polypeptide and protein–polymer bioconjugate hybrid materials
Alconcel et al. Synthesis of biotinylated aldehyde polymers for biomolecule conjugation
Steinbach et al. Squaric acid mediated bioconjugation expanded to polymers prepared by ATRP